Lv423
594 积分 2021-09-12 加入
Ibrutinib in early stage CLL: Genetic risk factors and treatment outcome in the GCLLSG CLL12 trial
16小时前
求助中
Reduced Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma – a Phase II Study
17小时前
已完结
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL)
17小时前
已完结
BCL-2 in leukemia: Enhancing clinical utility
17小时前
求助中
Exercise Prehabilitation for Older Adults Undergoing CAR-T: Feasibility, Acceptability, and Preliminary Outcomes
1天前
已完结
Bispecific CAR T and CAR NK cells in dual-threat immunotherapy: opportunities and challenges
1天前
已完结
Selinexor in combination with azacitidine or ruxolitinib in myelodysplastic/myeloproliferative neoplasm overlap syndromes: A multicenter prospective study
1天前
已完结
CAR cellular therapies for acute myeloid leukemia: current landscape and future directions
1天前
已完结
Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis
1天前
求助中
Recent advances in bispecific natural killer cell engagers for cancer immunotherapy
1天前
已完结
皖公网安备34019202002308
